Baotou Dongbao Bio-Tech Co Ltd (300239) — Capital Reinvestment Ratio

Latest as of September 2025: 2.21x

Baotou Dongbao Bio-Tech Co Ltd (300239) has a Capital Reinvestment Ratio of 2.21x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥8.19 Million) in capital expenditures (CN¥18.10 Million). See Baotou Dongbao Bio-Tech Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.21x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥8.19 Million
CNY

Capital Expenditures

CN¥18.10 Million
CNY

Data as of

Sep 2025
Most recent filing

Baotou Dongbao Bio-Tech Co Ltd Capital Reinvestment Ratio (2009–2025)

This chart tracks Baotou Dongbao Bio-Tech Co Ltd's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Baotou Dongbao Bio-Tech Co Ltd (2009–2025)

Year-by-year Capital Reinvestment Ratio for Baotou Dongbao Bio-Tech Co Ltd from 2009 to 2025. For live market cap and broader valuation context, see 300239 market cap overview.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.75x CN¥105.92 Million CN¥79.27 Million ▼ -33.0%
2024 1.12x CN¥69.13 Million CN¥77.17 Million ▲ +68.3%
2023 0.66x CN¥199.39 Million CN¥132.24 Million ▲ +19.3%
2022 0.56x CN¥195.32 Million CN¥108.56 Million ▼ -44.3%
2021 1.00x CN¥51.50 Million CN¥51.35 Million ▼ -58.6%
2020 2.41x CN¥63.13 Million CN¥151.93 Million ▲ +161.4%
2018 0.92x CN¥60.00 Million CN¥55.23 Million ▼ -76.3%
2016 3.89x CN¥40.54 Million CN¥157.73 Million ▲ +110.0%
2015 1.85x CN¥45.57 Million CN¥84.43 Million ▼ -29.2%
2013 2.62x CN¥9.08 Million CN¥23.77 Million ▼ -73.4%
2012 9.84x CN¥5.46 Million CN¥53.71 Million ▲ +357.7%
2011 2.15x CN¥24.22 Million CN¥52.07 Million ▲ +163.8%
2010 0.82x CN¥11.88 Million CN¥9.69 Million ▲ +15.7%
2009 0.70x CN¥13.83 Million CN¥9.74 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow